...
首页> 外文期刊>Journal of Inclusion Phenomena and Macrocyclic Chemistry >Enhancement of dissolution rate of valdecoxib by solid dispersions technique with PVP K 30 & PEG 4000:preparation and in vitro evaluation
【24h】

Enhancement of dissolution rate of valdecoxib by solid dispersions technique with PVP K 30 & PEG 4000:preparation and in vitro evaluation

机译:PVP K 30和PEG 4000固体分散技术提高伐地昔布的溶出度:制备和体外评价

获取原文
获取原文并翻译 | 示例

摘要

Solid dispersions of valdecoxib were prepared with the objective of dissolution enhancement by melt granulation technique using polyvinyl pyrollidone(PVP K 30)and polyethylene glycol(PEG 4000)alone(1:1)and in combination(1:0.5:0.5).Phase solubility studies showed a linear increase in valdecoxib solubility with increase in polymer concentration in both the cases.The FTIR spectroscopic studies showed the stability of valdecoxib and absence of well defined valdecoxib-PVP K 30-PEG 4000 interaction.Powder X-ray diffraction(XRD)and differential scanning calorimeter(DSC)were used to characterize the solid state of the dispersion,indicated a complete transformation of drug from crystalline to amorphous form.In vitro dissolution studies performed in 0.1 N HCl showed a significant enhance in dissolution rate when PEG 4000 and PVP K 30 were used in combination.Improved drug dissolution by both the carriers may be attributed to the improved wettability,reduction in drug crystallinity and solubilizing effects from solid dispersions of valdecoxib.Accelerated stability studies of solid dispersion with PVP K 30 and PEG 4000 does not show any significant change in the drug content and dissolution profile in 6 months study period.This study concluded that the dissolution rate of valdecoxib can be modulated by appropriate levels of hydrophilic carriers.
机译:以聚乙烯吡咯烷酮(PVP K 30)和聚乙二醇(PEG 4000)单独(1:1)和组合(1:0.5:0.5)的熔融造粒技术为目的,通过溶解制粒的方法制备伐地昔布的固体分散体。研究表明,两种情况下伐地考昔的溶解度随聚合物浓度的增加呈线性增加.FTIR光谱研究表明伐地考昔的稳定性以及没有明确定义的伐地考昔-PVP K 30-PEG 4000相互作用。粉末X射线衍射(XRD)差示扫描量热仪(DSC)表征了分散体的固态,表明药物从结晶形式完全转变为无定形。在0.1 N HCl中进行的体外溶出研究表明,当PEG 4000和结合使用PVP K 30.两种载体改善的药物溶解性可能归因于提高的润湿性,降低的药物结晶度和增溶性PVP K 30和PEG 4000对固体分散体的加速稳定性研究显示,在6个月的研究期间,药物含量和溶出度没有明显变化。被适当水平的亲水性载体调节。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号